# ADCytherix funding rounds and investors

As of 14 Oct 2026, ADCytherix has raised $122.3M across 1 verified round on record (amounts in other currencies converted to USD); latest: €105 million (US$ 122 million) Series A led by Andera Partners, Angelini Ventures and 2 others, announced 16 Oct 2025.

Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.

Website: https://adcytherix.com  
Headquarters: Marseille, France  
Page: https://fireround.dev/companies/adcytherix.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-10-16 | Series A | €105 million (US$ 122 million) | Andera Partners, Angelini Ventures, Bpifrance, Kurma Partners | aMoon, DawnBiopharma, Pontifax, Pureos Bioventures, RA Capital Management, Surveyor Capital (a Citadel company) | [adcytherix.com](https://www.adcytherix.com/post/adcytherix-raises-eur-105m-series-a-to-accelerate-breakthrough-antibody-drug-conjugate-pipeline-with), [globenewswire.com](https://www.globenewswire.com/news-release/2025/10/16/3167678/0/en/adcytherix-raises-eur-105m-series-a-to-accelerate-breakthrough-antibody-drug-conjugate-pipeline-with-strategic-focus-on-novel-payloads.html) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.